KYNTRA BIO, INC. Accumulated Other Comprehensive Income
KYNTRA BIO, INC. (KYNB) had Accumulated Other Comprehensive Income of -$1.19 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.19M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.89M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.18M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.21M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$1.19M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$1.89M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$2.18M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$2.21M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$4.79M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$4.43M 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$5.73M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$5.63M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$3.81M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$6.51M 10-Q · filed 2024-05-06 |
| 2023-12-31 | -$6.88M 10-K · filed 2025-03-17 |
| 2023-09-30 | -$6.92M 10-Q · filed 2023-11-06 |
| 2023-06-30 | -$6.25M 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$4.57M 10-Q · filed 2023-05-08 |
| 2022-12-31 | -$5.72M 10-K · filed 2024-02-26 |
| 2022-09-30 | -$7.35M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$6.93M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$6.50M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$4.16M 10-K · filed 2023-02-27 |
| 2021-09-30 | -$4.16M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$4.57M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$4.62M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$4.50M 10-K/A · filed 2022-03-04 |
| 2020-09-30 | -$4.26M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$1.56M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.18M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$747.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | -$224.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$462.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$937.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$2.28M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$2.57M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$2.61M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$3.62M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$1.79M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$1.61M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$1.39M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$1.02M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$960.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | -$1.33M 10-Q · filed 2016-11-08 |
| 2016-06-30 | -$1.02M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$1.70M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$1.65M 10-K · filed 2017-03-01 |
| 2015-09-30 | -$1.61M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$623.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$738.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | -$3.15M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |